Data as of Q4 2025 (Dec 31, 2025)
โณ
Showing Q3 2025 data
TYBOURNE CAPITAL MANAGEMENT (HK) LTD's Q4 2025 filing not yet available. Expected by Feb 14, 2026.

TYBOURNE CAPITAL MANAGEMENT (HK) LTD

โ€ขCIK: 1553936โ€ขFiling: Q3 2025

**TYBOURNE CAPITAL MANAGEMENT (HK) LTD** maintains a focused, concentrated portfolio approach with $31M in assets under management. The fund's current holdings are anchored by significant allocations to TSHA ($12.1M) and FBRX ($11.8M), representing the vast majority of its disclosed positions. The remaining capital is strategically deployed across ALMS ($5.6M) and ZNTL ($1.5M). This structure suggests a high-conviction, sector-specific investment mandate.

Total AUM
$30.9M
QoQ Performance
-10.4%
Positions
4
Top 10 Concentration
100.0%
Latest Filing
Q3 2025

Top Holdings Allocation

TSHA
FBRX
ALMS
TSHA39.1%
FBRX38.1%
ALMS18.0%
ZNTL4.7%

๐Ÿ“ˆ Biggest Buys

No new positions or increases this quarter

๐Ÿ“‰ Biggest Sells

TSHA
TAYSHA GENE THERAPIES INC (TSHA US)
-9.6%
39.1% of portfolio
ZNTL
ZENTALIS PHARMACEUTICALS INC (ZNTL US)
-35.0%
4.7% of portfolio

Sector Breakdown

Other100.0%

๐Ÿšช Exited Positionssold since Q2 2025

BCYC
BICYCLE THERAPEUTICS LTD-ADR (BCYC US)
SOLD
$6.9M
MBUU
MALIBU BOATS INC (MBUU US)
SOLD
$2.1M

Changes from Q2 2025

โ†“2 decreased

Historical Filings

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023